New shot aims to tame severe eczema itch
NCT ID NCT06727552
Summary
This study is testing whether an investigational drug called barzolvolimab can safely reduce severe itching and improve skin in adults with moderate to severe atopic dermatitis (eczema). About 131 participants will receive either the drug at one of two doses or a placebo via injection every four weeks for 16 weeks. The main goal is to see how much the treatment reduces daily itch scores compared to a placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
310 Clinical Research
Inglewood, California, 90301, United States
-
Acclaim Clinical Research
San Diego, California, 92120, United States
-
Advanced Dermatology Center - Burbank
Burbank, California, 91506, United States
-
Allergy and Asthma Specialists PSC
Owensboro, Kentucky, 42301, United States
-
Avance Trials
Laguna Niguel, California, 92677, United States
-
Bernstein Clinical Research Center, LLC
Cincinnati, Ohio, 45236, United States
-
Cahaba Dermatology & Skin Health Center, LLC
Birmingham, Alabama, 35244, United States
-
Center for Clinical Studies LTD.LLP
Webster, Texas, 77598, United States
-
Center for Medical Dermatology + Immunology Research
Chicago, Illinois, 60657, United States
-
Centricity Research Columbus Dermatology
Columbus, Georgia, 31904, United States
-
Direct Helpers Research Center
Hialeah, Florida, 33012, United States
-
Dynasty Dermatology
Pasadena, California, 91105, United States
-
Equity Medical LLC
Bowling Green, Kentucky, 42104, United States
-
Equity Medical, LLC
New York, New York, 10023, United States
-
Excel Clinical Research
Las Vegas, Nevada, 89109, United States
-
FOMAT Medical Research - Allergy, Asthma, & Immunology Medical Group
Ventura, California, 93003, United States
-
Focus Clinical Research
West Hills, California, 91307, United States
-
Georgia Skin and Cancer Clinic
Savannah, Georgia, 31419, United States
-
International Dermatology Research Inc - Miami
Miami Lakes, Florida, 33144, United States
-
Jordan Valley Dermatology Center - South Jordan
South Jordan, Utah, 84095, United States
-
LA Universal Research Center, Inc.
Los Angeles, California, 90057, United States
-
Ohara Aivaz MD Dermatology
Beverly Hills, California, 90212, United States
-
Onyx Clinical Research - Michigan
Flint, Michigan, 48532, United States
-
OptiSkin Medical
New York, New York, 10128, United States
-
Palmetto Clinical Trial Services LLC
Simpsonville, South Carolina, 29615, United States
-
Revival Research Institute, LLC
Troy, Michigan, 48084, United States
-
Sarasota Clinical Research
Sarasota, Florida, 34233, United States
-
Sienna Dermatology
Sugar Land, Texas, 77479, United States
-
Sneeze Wheeze and Itch Associates LLC
Normal, Illinois, 61761, United States
-
Treasure Valley Medical Research
Boise, Idaho, 83706, United States
-
UCLA Division of Dermatology
Los Angeles, California, 90089, United States
-
Well Pharma Medical Research Corporation
South Miami, Florida, 33173, United States
-
Zenos Clinical Research
Dallas, Texas, 75230, United States
Conditions
Explore the condition pages connected to this study.